Rosiñol Dachs, L., Oriol, A., Rios, R., Blanchard, M. J., Jarque, I., Bargay, J., . . . Bladé, J. (. (2023). Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myeloma.
Citação norma ChicagoRosiñol Dachs, Laura, et al. Lenalidomide and Dexamethasone Maintenance With or Without Ixazomib, Tailored By Residual Disease Status in Myeloma. 2023.
Citação norma MLARosiñol Dachs, Laura, et al. Lenalidomide and Dexamethasone Maintenance With or Without Ixazomib, Tailored By Residual Disease Status in Myeloma. 2023.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.